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Abstract 
Alshudukhi, Abdullah Ali. M.S. Department of Biochemistry and Molecular  
Biology, Wright State University, 2017. Exploring the role of lipin1 in mitophagy 
process using lipin1 deficient-EGFP tagged LC3 transgenic mice 
Lipin1 (phosphatidic acid phosphatase) is a key molecule in the cells with two functions: 
first, it converts phosphatidic acid into diacylglycerol in the cytosol which in turn makes 
triglycerides.  Second, in nucleus lipin1 acts as a transcriptional factor which regulates 
the expression of genes involved in the fatty acid oxidation and lipid metabolism. 
Clinically, Lpin1 gene mutations have been detected in patients with severe 
rhabdomyolysis accompanied with aggregated and dysfunctional mitochondria in their 
type II muscle fiber. Previously, we have observed that mice with lipin1 deficiency had 
aggregated mitochondria and abnormal autophagosomes formations by electron 
microscopy. The mechanism underlying the mitochondrial alterations observed in 
rhabdomyolysis patients is not revealed yet. Therefore, we think there is a link between 
impaired mitophagy and lipin1 deficiency in skeletal muscle. Mitochondrial quality 
control is responsible for regulating the turnover of the mitochondria within the cells. 
Mitochondrial autophagy (mitophagy) is a part of the mitochondrial quality control and 
considered as a key process within the eukaryotes. Dysregulated mitophagy has been 
shown to be involved in Parkinson's disease, cardiovascular diseases and 
neurodegenerative disorders. In this project we want to examine the role of lipin1 
deficiency on the impaired mitophagy process in the muscular tissue. We generated a 
unique mice model called lipin1-/--EGFP-LC3 transgenic mice to study the mitophagy 
process. This unique model expresses GFPs tagged to autophagosomes in mitophagy. 
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After analyzing the tissue specimens from the mice we observed increased 
autophagosomes vacuoles in the lipin1-/- -EGFP-LC3 transgenic mice in the glycolytic 
muscles fibers compared to the wild type (WT). These autophagosomes represent 
mitochondrial autophagy. The mitophagy in this context is mediated by Bnip3 (a 
mitochondrial damage marker) as we found it to be significantly upregulated in the 
lipin1-/- -EGFP-LC3 transgenic mice. We further treated the mice animals, WT and 
lipin1-/- -EGFP-LC3 transgenic mice, with chloroquine diphosphate (CQ) which act as 
autophagy inhibitor and cyclosporine A (CsA), which has been commonly used to 
improve mitochondrial membrane potential. CQ treatment inhibited the mitophagy and 
resulted in increased accumulation of LC3 (an autophagy marker) and Bnip3 in the both 
WT and lipin1-/- -EGFP-LC3 transgenic mice. CsA treatment was effective in increasing 
the mitochondrial membrane potential which led to decrease expression of the LC3 and 
Bnip3 in the cytosol of both WT and lipin1-/- -EGFP-LC3 transgenic mice. Lipin1 
deficiency upregulated AMP-activated protein kinase (AMPK) in fasting status through a 
stress produced by nutrients imbalance. AMPK activates FOXO3 (a transcription factor 
belongs to the forkhead box O-3 family) which has been shown to increase transcription 
of LC3 and Bnip3 genes. We found that the gene expressions of the LC3 and Bnip3 of 
lipin1-/- -EGFP-LC3 transgenic mice were slightly increased compared to WT suggesting 
that the accumulated proteins in the cytoplasm was partially due to increased 
transcription activity of these molecules. Also, we do not rule out that the increased 
protein expression in the cytosol is caused by blockage in the mitophagy process as well. 
Based on these findings, lipin1 deficiency may contribute to the impaired mitophagy in 
the lipin1-/- -EGFP-LC3 transgenic mice which leads to muscle weakness and atrophy.  
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I- Introduction 
i- Autophagy 
 
Eukaryotic cells are programmed to function in a concise manner. It keeps the 
cells performing properly and eliminating any harmful molecules that affect their 
survival. In the cells there is a system that is responsible for degrading and recycling the 
cytoplasmic proteins and organelles called autophagy. Autophagy is known as the 
engulfment process of dysfunctional proteins and defective organelles and subsequently 
degrade the components by lysosomes and recycle them for the cellular use (Cuervo, 
2004).  The recycled materials would provide amino acids and energy ready for cellular 
consumption.  Autophagy is in charge of eliminating and breaking down long-lived and 
impaired proteins as well as organelles. Thus, autophagy is crucial for cellular integrity 
to ensure a healthy environment within the cytosol and minimize the defects.  
Alterations in autophagy function lead to numerous diseases and disorders. 
Aggregated proteins and increased number of impaired organelles are going to 
negatively affect the cellular functions leading to cellular damage and death. Impaired 
autophagy has been linked to the induction of several diseases, for instance cancer, 
autoimmune diseases, and neurodegenerative diseases (Cuervo, 2004). For instance, 
Beclin 1, is a mammalian autophagy gene which inhibits cancer induction, was greatly 
reduced in human breast carcinoma (Liang et al., 1999). Another paper also revealed 
that genetic mutations occurred in Ultraviolet (UV) radiation resistance–associated gene 
(UVRAG) (an autophagy inducing gene) reduced the autophagy activity in gastric 
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carcinoma (Kim et al., 2008). Frameshift mutations in the polyadenine tract were 
developed in the UVRAG led to microsatellite instability as the paper reported. 
Autophagy seems to play a critical role in preventing cancer emerging, therefore any 
defect in autophagy proteins would suppress the defense mechanism and enhances the 
diseases emerging.  
i.1       Important Biomarkers/pathway in autophagy         
Balancing between protein biosynthesis and degradation is essential for cellular 
homeostasis and this task can be done by autophagy. One of the important molecule of 
autophagy is microtubule‐associated protein 1 light chain 3 (LC3). LC3 associates with 
the phagophore (autophagosome) membrane allowing the cytoplasmic components to be 
engulfed and degraded (Kabeya et al., 2000).  This molecule expressed in the cytosol is in 
two forms, LC3-I as unbound form in the cytosol. The other form is LC3-II, which is 
expressed on the autophagosomes membrane, is made by incorporating 
phosphatidylethanolamine (PE) to LC3-I which allows LC3-II to bind to the 
autophagosomes membrane (Kabeya et al., 2000). The function of LC3 protein is to 
interact with other autophagy adaptors which are bound to the defective material to 
complete the engulfment process. In monitoring autophagy, LC3 has been used as a 
marker to study the autophagy either by tissue immunostaining or via measuring the 
protein level of the LC3 (Yoshii & Mizushima, 2017). The amount of the LC3-II proteins 
represents the abundance of autophagosomes (Kabeya et al., 2000). Thus, using LC3 as a 
tool to study the autophagy/mitophagy would facilitate the process and provide a precise 
criteria to evaluate the engulfment process.  
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There are other autophagy molecules which interact with cellular organelles and 
are essential for their autophagic engulfment such as p62/SQSTM1. This molecule is also 
named as the autophagy adaptor and is required in the interaction between LC3 and 
engulfed cargo. P62 directly interacts with LC3 and facilitates the engulfment and the 
aggregation of the defective proteins (Pankiv et al., 2007). Once the materials are 
engulfed, the p62 will be degraded as well as the engulfed components in the 
autophagosomes by lysosomal enzymes.  
  Autophagosomes are double membrane structures that are created in the cytosol 
to engulf defective molecules and organelles and deliver them to lysosomes for 
degradation (Mizushima, 2004). This process of making autophagosomes required 
activation and recruitment of several autophagy proteins. To activate the autophagy 
machinery, the cells first produce a damage-induction signal which suppresses the 
activity of the mammalian target of rapamycin (mTORC1). The downregulated mTORC1 
allows the activation of Unc-51-like kinase 1 (ULK1) complex (an autophagy related 
molecule) which in turn binds to phosphatidylinositol 3-kinase (PI3K) complex on the 
Endoplasmic Reticulum (ER) membrane. Once these complexes are translocated to the 
ER membrane they generate a structure called pre-autophagosomal structure (PAS) with 
involvement of other molecules like vacuole membrane protein 1 (VMP1) and Atg9.  
After that, the ER membrane undergoes some changes which resulted in formation of 
omegasome as a start of the isolation membrane creation. The PI3K recruits its effectors 
to the ER membrane which leads to increase production of phosphatidylinositol 3-
phosphate (PI3P) at that specific site. Generation of local PI3P may help in building the 
isolation membrane. Lastly, Atg16L recruits LC3 and perform LC3 lipidation by 
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incorporating phosphatidylethanolamine (PE) which allows LC3 to bind to the 
autophagosome membrane. Finally, the isolation membrane expanded and then released 
form the ER membrane to continue the autophagy process. This was a brief explanation 
of the autophagosome formation as it described in more details in this review 
(Mizushima, Yoshimori, & Ohsumi, 2011).  
ii- Mitophagy  
 
Dysfunctional mitochondria can be cleared through autophagy process. This 
selective autophagy of mitochondrial is also known as mitophagy. The mitophagy 
process is responsible for removing damaged mitochondria and delivering them to 
lysosomes for degradation (Yoshii & Mizushima, 2015).  Mitochondrion is one of the 
vital organelles within the cells. It’s involved in several significant and cell’s life-
dependent biological processes, such as, energy production, metabolism, signaling, 
apoptosis and cell differentiation. Therefore, due to multiple mitochondrial functions, the 
mitochondria may develop several types of damage with time during their life (Gomes & 
Scorrano, 2013). Once this happens, the cells detect intracellular signals that show where 
the damaged parts are and start to eliminate that from the cytosol. Mitochondrial 
autophagy (mitophagy) is a mechanism where the cells use to repair or eliminate defects. 
This occurs through the mitochondrial expression of damage markers on the outer 
membrane in order to be recognized then engulfed and removed from the cytosol (Yoshii 
& Mizushima, 2015). Mitochondrial autophagy is essential for mitochondrial network 
and maintains good members within the cellular community.    
The mitophagy is significantly required for the cell’s functioning and survival and 
preventing development of diseases. Misfolded protein, reactive oxygen species (ROS) 
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species and defective mitochondrial components cause mitochondrial damages. 
Eventually, these damages would negatively influence the cells and impair their 
functions. For a larger picture, these mitochondrial abnormalities would affect the organs 
functions and cause several diseases such as Parkinson's disease, cardiovascular diseases 
and neurodegenerative disorders (Kanki, Furukawa, & Yamashita, 2015; Redmann, 
Dodson, Boyer-Guittaut, Darley-Usmar, & Zhang, 2014). This shows how important the 
mitophagy is in the cells integrity and physiology. Clearing up ROS and defective 
mitochondria result in maintained mitochondrial functions and cellular homeostasis. The 
mitochondrial autophagy is capable of recycling the waste products and damaged 
mitochondria in order to keep the cell’s functions and existence.  
iii- Biomarkers/Pathways for Mitophagy 
 
The activation of mitophagy is regulated by numerus molecules and proteins. 
Upon damage to mitochondrion, the organelle expresses proteins and markers on its 
surface. The role of the damage markers is to decorate defective mitochondria for the 
recognition by the eliminating system, mitophagy. There are several known markers for 
damage expressed on the mitochondria. For instance but not limited to, PTEN-induced 
putative kinase 1 (PINK1), NIP3-like protein X (NIX), Bcl-2/adenovirus E1B 19-kDa-
interacting protein 3 (Bnip3), and Parkin (Yoshii & Mizushima, 2015). Basically, these 
markers get expressed on the outer membrane of the mitochondria and allow their 
interaction with LC3 directly or via p62 (a general autophagy adaptor) protein to 
complete the engulfment by the phagophores. Therefore, the mitochondrial damage 
markers are highly important in the process of recognizing impaired mitochondria and 
recruiting the autophagy machinery to eliminate them from cytoplasm.   
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Bnip3 is considered as one of the main mitophagy pathways by which 
mitochondria get recognized and isolated from the healthy mitochondrial network. 
Sequestration of mitochondria in a double membrane requires these damage molecules to 
interact either directly with LC3 or through p62. Bnip3 has the ability to directly bind to 
LC3 as a mitophagy adaptor (Hanna et al., 2012). This interaction occurs through the 
LC3 interacting region (LIR) which consists of a WXXL motif in the Bnip3 protein.  
Thus, Bnip3 is a key molecule in the mitochondrial autophagy since it acts as a damage 
marker and as a mitophagy adaptor. Another mitophagy marker is Parkin, this molecule 
translocates from cytoplasm to the dysfunctional mitochondria to tag them for mitophagy. 
Once Parkin is bound to the mitochondria, it enhances the mitophagic machinery 
recognition of the dysfunctional organelle (Narendra, Tanaka, Suen, & Youle, 2008). 
This interaction occurs through recruitment of p62 to facilitate the engulfment by 
autophagosome (Matsuda et al., 2010). Molecules of mitophagy are either recruited to the 
mitochondria or expressed from the internal of mitochondria on the surface. The 
significance of these markers is based on their interactions with autophagic machinery.   
iv- Mitochondrial membrane potential and mitochondrial quality control  
 
Alteration in mitochondrial membrane potential leads to initiation of autophagy. 
One of the important criterion that associates with mitochondrial activity is mitochondrial 
membrane potential. Mitochondrial membrane potential has been used as a representative 
of the mitochondrial functionality (Brand & Nicholls, 2011). The H+ proton gradient 
across the inner mitochondria membrane creates the membrane potential in the 
mitochondria. These protons pass the inner membrane through the ATP synthase 
complex to make ATP via oxidative phosphorylation and provide energy for the cell 
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(Saraste, 1999). This is one of the major functions of the mitochondria. In case of 
abnormality, hyperpolarization (increased membrane potential) of the mitochondria 
produces ROSs which are known to affect the cellular molecules and functions. Increased 
mitochondrial membrane potential has been linked to disease development such as 
Alzheimer’s, cancer and diabetes (Huttemann et al., 2008). On the other hand, 
depolarization (decreased membrane potential) of the mitochondrial membrane leads to 
cellular damage and impaired mitochondrial function, which eventually leads to inability 
to produce energy to meet cellular needs. Altering physiology of mitochondrial 
membrane potential has also been associated to negatively influence the mitochondrial 
performance in particular. Several reports have shown that impaired mitochondrial 
membrane potential disrupt the fission/fusions events of the mitochondria and 
furthermore influence mitochondrial quality control and the mitophagy process (Matsuda 
et al., 2010; Twig et al., 2008).   
The mitochondrial quality control regulates the mitochondrial existence, energy 
generation and damage repair. The mitochondrial quality control involves fusion and 
fissions events to control the mitochondrial network and provide more efficient 
functioning organelles (Romanello & Sandri, 2015). Fusion for instance, allows the fused 
mitochondria to exchange their metabolites, proteins and mtDNA. Eventually, they 
increase the amount of energy they produce and increase the performance of the 
mitochondrial functions in general. In addition, the fusion also offers a great feature 
where it buffers the damage when two mitochondria fuse together and allow them to 
repair that damage (Twig et al., 2008). On the contrary, fission does the opposite where it 
segregates the impaired or defective mitochondria from the network and degrade them 
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through the mitophagy process (Figure 1). The mitochondrial quality control ensures the 
balance between fusion and fission in order to maintain a healthy mitochondrial network.  
 
 
Figure 1 : Schematic diagram for the Mitochondria quality control cycle (Kluge, 
Fetterman, & Vita, 2013).  
 
Many studies have revealed that alteration in the mitochondrial quality control 
caused several serious illness. Cai and Tammineni (Cai & Tammineni, 2016) have 
showed that disturbing the mitochondrial quality control led to defects associated with 
Alzheimer’s disease. Abnormal events in the mitochondrial quality control such as 
aggregated mitochondria within axons was observed in mice with mutated Mfn2 
(Detmer, Vande Velde, Cleveland, & Chan, 2008). Mfn2 is one of the mammalian 
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mitochondrial fusion-related proteins that is required for the outer mitochondrial 
membrane fusion process. With many key cellular functions governed by mitochondria, 
imbalanced mitochondrial quality control has the potential to adversely affect the 
cellular activities and eventually contributes to diseases onset and progression.  
 
v- Mitochondrial membrane Lipids and mitochondrial quality controls  
 
Mitochondrial membrane lipid composition affects mitophagy. Cardiolipin is one 
of the unique lipids within the cells associated with mitochondria. It’s localized in the 
inner mitochondrial membrane and contributes to several functions such as energy 
metabolism and mitophagy. Recently, it has been shown that cardiolipin interacts with 
LC3 protein to enhance the engulfment of the mitochondria by autophagosomes (Chu et 
al., 2013).  Moreover, cardiolipin involved in mitochondrial membrane remodeling which 
is required for the membrane fusion process (Cullis, Hope, & Tilcock, 1986). In fusion 
events, cardiolipin contributes to the regulation of mitochondrial fusion by modifying the 
morphology of mitochondria (Ban et al., 2017). However, depending on peroxidation 
cardiolipin can either activate mitophagy or apoptosis in the cells (Ren, Phoon, & 
Schlame, 2014). Moreover, the mitochondrial membrane lipids contain phospholipids 
such as phosphatidic acid (PA) and diacylglycerol (DAG). The PA has been shown to 
regulate the mitochondria aggregation and fusion processes (H. Chen et al., 2003; Ha & 
Frohman, 2014).  The DAG lipid enhances the mitochondrial fission. It has been 
suggested that DAG may recruit proteins that initiate fission process (Ha & Frohman, 
2014). Lipin1 (phosphatidic acid phosphatase) regulates mitochondrial fission and fusion 
events by converting PA into DAG on the mitochondrial surface and then participates in 
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the regulation of these events (Ha & Frohman, 2014; Huang et al., 2011). Taken together, 
lipids of mitochondrial membrane are essential for the organelle activity.  Changes in 
mitochondrial membrane lipid composition can significantly affect the mitophagy and 
mitochondrial quality control.   
  
 v.1        Lipin1  
Lipid metabolism is regulated by proteins that govern synthesis, transporting and 
elimination of lipids. One of the protein groups that regulate lipid metabolism is Lipin 
proteins.  Lipin proteins family are a group of phosphatases that regulate the expressions 
of several genes that involve in the fatty acid oxidation and lipid metabolism. The lipins 
also play a significant role in the biosynthesis of the fats and regulate their levels within 
the cytoplasm (Hu, 2015). This family includes lipin1, lipin2 and lipin3, in which lipin1 
is well known and studied (Michot et al., 2012). However, the other two lipins are less 
known and poorly studied (Y. Chen, Rui, Tang, & Hu, 2015). The lipin1 molecule 
participates in the synthesis of the phospholipids and triglycerides (TGs). The TGs are the 
most predominant and largest types of lipids in the cellular system. It is known to be the 
storage form of the fats in the biological cells. Adipocytes containing TGs are the energy 
house of the body and readily can be used to provide the body’s energetic needs to 
perform its functions.   
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Figure 2: Lipin1 protein structure and motifs (Y. Chen et al., 2015). 
 
Lipin 1 is a vital molecule within the cells with a dual functions. In the cytosol, 
lipin 1 acts as an enzyme with a dephosphorylation activity (Donkor et al., 2009). It does 
dephosphorylate phosphatidic acid (PA) to form diglyceride (DAG) which eventually 
generates triglycerides. Possessing a functional motif the haloacid dehalogenase (HAD)-
like phosphatase motif (DXDXT) allows lipin1 to perform this function and bind to its 
substrates (Figure 2). The other function of lipin1is a nuclear function. Lipin1 molecule 
enters the nucleus then it acts as a transcriptional factor to facilitate the expression of 
genes required for the fatty acids oxidation (Figure 3) (Harris et al., 2007). Similar to the 
enzymatic activity motif, lipin1 has a nuclear receptor interaction motif (LXXIL) 
required for the binding to the complex involved in the lipogenesis and fatty acid 
oxidation genes expressions (Harris et al., 2007). Lipin1 contains a nuclear localization 
signal (NLS) which allows the traffic of the molecule inside the nucleus.  
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Figure 3: The nuclear and cytoplasmic functions of the Lipin1 protein (Y. Chen et al., 
2015).  
It has been shown that lipin1 activity is regulated by mTOR pathway. The master 
molecule, mTOR, phosphorylates lipin1 and promotes its localization in the cytosol 
(Peterson et al., 2011). Being in the cytosol allows lipin1 to act as enzyme for the 
conversion of PA into DAG. On the contrary, when mTOR is inactive, lipin1 is 
dephosphorylated and crosses the nuclear membrane and serves as a transcription factor 
which then participates in the genetic expression of molecules involved in the lipid 
metabolism and fatty acid oxidation as is illustrated in Figure 4.    
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Figure 4: Schematic illustration of lipin1 molecular signaling pathway (Peterson et al., 
2011).  
 
Pathologically, lipin1 has been shown to develop genetic polymorphisms that 
affect glucose hemostasis. Peltonen and colleagues (Suviolahti et al., 2006) have tested 
some single nucleotide polymorphisms (SNPs) sites within the lipin1 gene and found that 
lipin1 mutations are involved in regulating insulin expression and lipids phenotypes. 
These studies revealed a crucial role of lipin1 in the pathogenesis and emerging of life-
threatening diseases. Defective lipin1’s functions and mutations have been linked to 
muscular abnormalities such as rhabdomyolysis, which is a breaking down of the 
muscular tissue leading to releasing its content into the blood stream (Zutt, van der Kooi, 
Linthorst, Wanders, & de Visser, 2014). A study reported that six 
deleterious mutations in the lipin1 gene were identified among a group children with 
severe rhabdomyolysis (Zeharia et al., 2008).  A recent clinical study was done by 
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Michot et al (2012) revealed that patients with severe rhabdomyolysis had autosomal 
recessive mutations affecting the lipin1 gene. In the previous study, the investigators 
examined more than 170 patients with muscular symptoms and rhabdomyolysis and 
found that 18 subjects had two lipin1 mutations with severe rhabdomyolysis. This study 
also showed that the rhabdomyolysis patients presented mitochondrial aggregations 
accompanied with altered mitochondrial function in skeletal muscle. In a previous work 
we generated, fatty liver dystrophy (FLD) mice, which lack lipin1, showed mitochondrial 
aggregations and abnormal autophagosomes formations in the skeletal muscles. These 
abnormalities in the mitochondria is suggested to be caused by the defect in the 
mitochondrial clearance from the cytosol. Therefore, we suggested a role of lipin1 in the 
impaired mitophagy and mitochondrial function. This project is aimed to study the role of 
lipin1 in the defective mitophagy.  
 
vi-  Approaches to study autophagy/mitophagy 
 
 A unique mice model was established by Dr. Ren (2016) to study the role of 
lipin1 in mitophagy. Fatty liver dystrophy mice lineage (as described in the methodology 
section) was crossed with a mice model which was generated by Dr. Mizushima’s lab  
(Mizushima & Kuma, 2008) that expresses green fluorescent protein along with 
Microtubule-associated protein light  chain 3 (LC3). So, the new mice model is called 
Lipin1-/- EFGP-LC3 transgenic mice, which is used in this study to monitor the 
mitophagy in skeletal muscles. What is unique about these mice is they can express GFP 
whenever there was LC3 protein expressed on the surface of the autophagosomes. 
Detecting the GFP signals is used to monitor the mitophagy and its function through use 
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of muscular tissue sections and visualize them by immunofluorescent microscope 
(Mizushima & Kuma, 2008).  
vii.      EDL vs Soleus 
In our study we chose the skeletal muscle tissue obtained from mice to investigate 
the role of lipin1 deficiency on mitophagy. Two types of muscles were collected from the 
mice in order to be studied and analyzed. The muscles are extensor digitorum longus 
(EDL) and soleus muscles obtained from the lower limbs of the mice from both genders. 
EDL is composed of fast-twitch type IIA and type IIB fibers mainly. While, the soleus 
muscle mostly consists of  slow-twitch fibers and type 1 and type IIA (James, 
Altringham, & Goldspink, 1995). Moreover, the EDL has been described as glycolytic 
muscle fibers, while the soleus known as the oxidative muscle fibers based on their 
energy metabolic modes. The properties of these muscles helped us to study the 
mitophagy and mitochondrial function under different situations and stresses. The EDL 
specifically, has been shown to present much increase in autophagosomes accumulation 
with the starvation compared to soleus muscle (Howells, Jordan, & Mathews, 1978; Y. 
Wang & Pessin, 2013). Therefore, fasting would generate great and significant effects on 
the EDL muscle tissues and on the cellular metabolic regulation. On the protein 
degradation level, the EDL muscle has been reported to present a higher rate of the 
mitophagy process compared to the soleus (Y. Wang & Pessin, 2013; Yamada et al., 
2012). EDL was a perfect model to study the mitophagy based on the differences in the 
muscle atrophy and autophagy activations pathways compared to soleus. For instance, 
upon fasting the autophagy seemed to be more pronounced in the EDL versus soleus 
(Howells et al., 1978). Soleus has a higher expression of Peroxisome proliferator-
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activated receptor-γ coactivator-1 (PGC1α) which protects the oxidative muscle from 
atrophy (Yamada et al., 2012). In the oxidative fiber muscles, upregulated PGC1α 
reduces the activity of FOXO3 and then downregulates the autophagy. On the contrast, 
several pathways are known to control muscle mass by regulating protein degradation 
and autophagy in the glycolytic muscle fiber, such as Forkhead box O family 
(Foxo), transforming growth factor beta (TGFβ) family, autophagy inhibition, and 
nuclear factor kappaB (NF-κB) (Y. Wang & Pessin, 2013). FOXO3 has been implicated 
in muscle wasting via induction of autophagy process by increasing the transcription of 
autophagy-related genes such as LC3 and Bnip3. Knocking out autophagy essential 
genes, such as ATG5 in the EDL muscle presented a higher reduction in the autophagy 
process (Raben et al., 2008). Another mechanism which makes the EDL more likely to 
initiate autophagy during starvation than soleus is due to the role of Fyn protein (a proto-
oncogene). Fyn has been shown to suppress autophagy through activation of mTORC1 
and inhibition of AMPK. The mechanism underlying the difference between EDL and 
soleus is thought to be via Fyn activity which has been shown to downregulate Vps34 (an 
autophagy initiating molecule) (Yamada et al., 2012). During starvation in EDL, Fyn 
activity is decreased which then leads to upregulation of Vps34 and increased autophagy 
activity. However, in the soleus Fyn showed no significant change during fasting so 
Vps34 activity was still inhibited in soleus. Based on this information, the EDL muscle 
was the main focus to investigate in our study. The muscle fiber types and the physiology 
of the EDL muscle were the main reasons to select this tissue to understand the role of 
lipin1 deficiency in defective mitochondrial autophagy.  
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vii- Hypothesis and specific aims:  
 
Mitophagy is crucial for cells existence and functionality. Dysfunctional 
mitophagy causes serious illness and disorders. For our knowledge, lipin1 serves as an 
enzyme converting PA to DAG, also acts as a transcriptional factor regulating genes 
expression in lipid metabolism. However, defective mitophagy in patients and mice 
model has been associated with lipin1 deficiency. Based on that, we are hypothesizing 
that lipin1 may has a role in impaired mitophagy process. Thus, in this project we are 
aiming to investigate the role of lipin1 deficiency in defective mitochondrial autophagy in 
skeletal muscles. To accomplish that, the following aims were proposed for this study:   
1) To investigate how lipin1 deficiency affects mitophagy process; 2) to visualize the 
effect of lipin1 deficiency on mitophagy process using Lipin1-/- -EGFP-LC3 transgenic 
mice; 3) to determine whether the improvement of mitochondrial membrane potential 
could ameliorate Lipin1-associated mitophagy defects. 
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II- Methods and Materials 
 
i- Generation of Lipin1 -\-- EGFP-LC3 transgenic mice: 
 
To generate the Lipin1 -\-- EGFP-LC3 transgenic mice we crossed Fatty liver 
Dystrophy (FLD) mice lineage (obtained from the Jackson Laboratory) with the 
Enhanced Green Fluorescent Protein –Microtubule Light Chain 3 (EGFP-LC3) tagged 
mice which was generated by Dr. Noboru Mizushima's lab (Mizushima, 2004). The mice 
genotyping was determined by obtaining mice tail snaps from new-born pups. These tails 
were digested by 0.5M EDTA solution (pH 8.0), Nuclei Lysis solution and Proteinase K 
mixture and incubated in water bath at 55Cْovernight. Afterword, the extraction steps 
were continued using isopropanol to clump and precipitate the DNA. 70% ethanol was 
used to wash the DNA and increase the DNA yield. Lastly, the extracted DNA was 
further used for PCR reactions to obtain the genotyping results of the mice using the 
following primers.   
The FLD animals were genotyped by a PCR program which detects the lipin1 
mutations, primers used are 5’-CCCTTGAGCACGTTCACA-3’,                                                    
5’-GGTTGTGGGGACCCTGGA-3’ and 5’-GCCTGCTGCAGATGCGTT-3’. The FLD 
program requires two reverse primers one for the wildtype and the other detects the 
mutated gene. EGFP gene was detected by a PCR program with the use of these primers 
5’-CCTACGGCGTGCAGTGCTTCAGC-3’ and                                                                    
5’-CGGCGAGCTGCACGCTGCGTCCTC-3’.  The DNA extraction protocol was 
obtained from this paper (Laird et al., 1991).  
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ii- Tissues collection: 
 
Upon establishment of the Lipin1 -\-- EGFP-LC3 transgenic mice, we treated the 
mice as illustrated in table-1. The treatment included Chloroquine Diphosphate (CD) 
agent which considered as a mitophagy inhibitor. The other chemical is Cyclosporine A 
(CsA) which has been used to increase the mitochondrial membrane potential via 
blocking the mitochondrial permeability transition pore (MPT).  
 
 
Table 1: Lipin1 -/- EGFP-LC3 transgenic mice treatment groups 
 
The age range of these mice was from 8 weeks up to 20 weeks.  The animals were 
euthanized after the treatments and the EDL and Soleus muscle tissues were collected. 
We applied the Optimal Cutting Temperature (OCT) over each muscle and dipped it in 
cold Isopentane (−160ْ C) for 10 seconds. After that store the tissues in the -80ْC freezer. 
For the immunofluorescent staining, we cut the muscles into thin sections between 5-7 u 
using Cryostat Thermo Scientific Microm HM550 (-20C).  
Treatment 
type 
Count 
of 
WT 
Count of 
Lipin1 -\-- 
EGFP-LC3 
Injection 
period 
Dosage 
Fasting 
after 
treatment 
Total 
number of 
mice 
Fasting 3 4 - - 16hrs 9 
CD 4 4 10 days 3.3ul /gram 16hrs 8 
CA 3 3 10 days 3.3ul /gram 16hrs 6 
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iii- Immunofluorescent staining: 
  
Immunofluorescent staining has been used to evaluate the autophagy in the tissue 
sections. Tissues were fixed with 4 % Paraformaldehyde for 15 mins at RT. 
Then after washing with 1X PBS, they get permeabilized with 0.3% Triton X-100 
(ThrrmoFisher, Surfact-Amps X-100, #28314) for 15 mins then washed. Two blocking 
solutions were utilized in this experiments, first blocked by M.O.M mouse IgG blocking 
regent (Vector Laboratories, MBK-2213) diluted in PBS for 1 hour at RT. Then slides 
were washed before adding the second blocking buffer (10 % goat serum+ 1% BSA in 
PBS) for 1 hour at RT then washed. Following the blocking, the muscle sections were 
incubated with 1ْAb overnight at 4ْC. The antibodies diluted in 10 % goat serum+ 1% 
BSA, i.e. LC3 and Bnip3 as 1:400 dilution factor.  On the next day, the secondary 
antibodies were added after washing the sections, and incubated at RT for 60-90 mins. 
The secondary antibodies diluted in (10 % goat serum+ 1% BSA in PBS), (Goat anti-
Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 555 #21428) by 1:500 dilution 
factor. Lastly, the slides were washed with PBS+ 0.01% Tween-20 5 x 5 mins, and 
allowed to dry before adding mounting medium (Vectorshield anti-fade containing DAPI 
(Vector- H-1200). The Immunofluorescent images were taken by LEICA DMI 6000 B 
microscope.  
 
iv- Western Blotting: 
 
The protein expression profiles of autophagy and mitophagy markers were 
measured using immunoblotting. Extracted muscles were homogenized with a mixture 
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that contains 1X RIPA buffer (20-188 EMD Millipore Sigma) + 0.2% Proteases 
Inhibitors (SIGMA cOmplete™ Protease Inhibitor Cocktail 04693116001) + 0.2% 
Phosphatases inhibitors (SIGMA P2850 - Phosphatase Inhibitor Cocktail 1), in which 
1ml 1X RIPA + 20 ul of protease inhibitor+ 20ul of Phosphatase inhibitor. Then, tissue 
homogenization was performed in the ice by adding for each 20mg of tissue 450ul of the 
homogenization mixture by using manual homogenizers. Then the samples were 
centrifuged at 12000rpm at 4Cْ for 10 minutes. In order to measure the proteins 
concentrations, the bicinchoninic acid assay (BCA) assay was utilized.  2mg/ml of bovine 
serum albumin (BSA) was used as standards (0, 1ul, 2ul, 3ul, 4ul, 5ul and 6ul loaded in 
96 well plates). The samples were added by 2ul and duplicated. The amount of samples 
needed to be resolved by the western blotting was determined by the standard curve from 
the BCA.  
  The lysates were ran in the acrylamide gel (30% acrylamide Solution 37.5:1 
Biorad Cat. 1610158) in order to separate the proteins. 12.5 % and 7.5 % of the 
acrylamide gels were used in our experiments according to the proteins sizes. The protein 
samples were mixed with 10ul of 4 x loading dye and boiled for 5 mins. After boiling the 
samples, they were spun and loaded into the acrylamide gels. The power box was set by 
voltage 120V once it goes through the stacking gel. For transferring the proteins, first, the 
PVDF membranes are cut and soaked in methanol for 1 minute then moved to transfer 
buffer. To transfer the proteins form the gel into the membrane the gel and the membrane 
were stacked in a gel holder cassette of the transfer system. Then, transferred them into 
the transfer box and sat up the power at 0.30 A and 150 V for 2 hours with ice 
surrounding the transfer box. To get rid of the unspecific binding casein solution was 
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utilized and diluted in 1X PBS with 1:9 ratio to block the membranes.  Blocking of the 
membrane was for 60 minutes at the room temperature. Most of our protein antibodies 
we obtained them form Cell Signaling Technology. We used LC3B (D11) XP® Rabbit 
mAb #3868, Parkin Antibody #2132, Phospho-PKD/PKCμ (Ser744/748) 
Antibody #2054, Phospho-p70 S6 Kinase (Thr389) Antibody #9205, p70 S6 Kinase 
Antibody #9202, Akt (pan) (C67E7) Rabbit mAb #4691, Phospho-Akt (Thr308) (D25E6) 
XP® Rabbit mAb #13038. From Abcam  Anti-GAPDH antibody [EPR16891] 
(Rb) (ab181602), Anti-BNIP3 antibody (Rb) (ab38621), Anti-SQSTM1 / p62 antibody 
[EPR4844] (Rb) (ab109012),  PKC mu Polyclonal Antibody (Rb) PA5-38387 Invitrogen. 
These antibodies were diluted in 10% casein + 0.1 % Tween 20. Blots were incubated 
with the antibodies for overnight at 4C◦. For secondary antibodies, Anti-Rabbit IgG 
(H+L), HRP Conjugate #W4018, Anti-Mouse IgG (H+L), HRP Conjugate #W4028. The 
secondary antibodies were incubated for 1 hour at the RT.  These antibodies were diluted 
in 10% casein + 0.1 % Tween 20 + 0.1% 10% SDS. To visualize the blots, a 
chemiluminescent kit was used from Pierce™ ECL Western Blotting Substrate 
catalog # 32106. Visualization of the blots was done by the Amersham Imager 600 
instrument.   
 
v- Quantitative PCR:  
 
The mRNA expression was evaluated for some of the mitophagy proteins to 
assess the transcription activity of the markers during different scenarios in the mutant 
mice. The extraction of the RNA was performed using a modified version of the 
Invitrogen protocol which involves TRIzol. Muscles were disrupted and homogenized by 
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TRIzol and pestle homogenizer. 1ml of TRIzol was added to each 20-30 mg of muscle 
mass. After the tissue disruption, Chloroform was added to the lysate to separate the 
RNA layer from the proteins phase. Isopropanol and 70% Ethanol were further used to 
clump the RNA and help in precipitation of RNA and increase the RNA yield. The 
complete extraction protocol is available online 
(https://tools.thermofisher.com/content/sfs/manuals/trizol_reagent.pdf). All the primers 
used in this study were purchased from Integrated DNA Technologies (IDT) as follow: 
LC3 primers 5’-TCGTTGTGCCTTTATTAGTGCATC-3’ and 5’- 
CACTGCTCTGTCTTGTGTAGGTTG-3’. Bnip3 primers 5’-
TTGGGGCATTTTACTAACCTT-3’ and 5’-TGCAGGTGACTGGTGGTACTAA-3’.  
Lipin1 primers 5’-CAGCCTGGTAGATTGCCAGA-3’ and 5’-
GCAGCCTGTGGCAATTCA-3’. P62 primers 5’-GCTCCAGTTTCCTGGTGGAC-3’ 
and 5’-GCACCTGTCTGAGGGCTTCT-3’. The qPCR experiments were done using 
QuantStudio™ 7 Flex Real-Time PCR System from TheromFisher Scientific Company.  
 
vi- Experimental design:  
 
In Figure 5 we are summarizing the experiments that we used in our project. 
Beginning from establishing the mice model then injecting the mice with CD and CA. 
Then mice were euthanized and muscles were collected. Following different tissue 
homogenizations, proteins or RNA were extracted in order to perform western blotting or 
qPCR analysis. Also, the muscle were cut into thin sections in order to visualize the 
autophagosomes and stain with antibodies against some molecules.   
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Figure 5: Schematic illustration of the experimental design for our project  
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III- Data and results 
Aim 1: To investigate how lipin1 deficiency affects mitophagy process. 
1- The novel lipin1 deficient EGFP-LC3 transgenic mice model expresses 
endogenous GFP. 
 
The main goal for establishing the lipin1 deficient EGFP-LC3 transgenic mice 
model is to provide a reliable tool to investigate the mitochondrial autophagy in vivo. 
Therefore, we want to examine the muscle tissue of the new mice model to check 
whether they can express endogenous GFPs or not. After we analyzed the tissue samples 
from the lipin1 -/- EGFP-LC3 transgenic mice, we were able to visualize the GFP 
punctates in the EDL muscle using immunofluorescent microscope (Figure 6). These 
GFP dots represent the autophagic vacuoles formed in the cells as it has been shown 
before (Kabeya et al., 2000). Since these mice are genetically modified to express GFP 
along with expressed LC3 protein we did not stain the cryosections with any antibody 
against LC3. These sections were only stained with DAPI and fixed with 
paraformaldehyde. All the wild type (WT) muscles we used in this study they express 
GFP protein tagged to LC3 protein. At the basal level, WT EDL muscle showed a basal 
level of the autophagosomes created in the cytoplasm as the image shows in (Figure 6, 
upper panel). However, after fasting (16 hours) the number of the phagophores in the WT 
was higher due to an increased autophagy/mitophagy rate to provide energy to the cells 
(Kuma et al., 2004). Fasting is commonly used to physiologically trigger the 
autophagy/mitophagy process in the cells without the need for any chemical agents 
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(Alirezaei et al., 2010; Levine & Kroemer, 2008). Comparing the lipin1 deficient EGFP-
LC3 mice muscles to the WT, in basal status the GFP punctates were higher and bigger in 
size versus the WT basal (Figure 6, lower panel). In contrast, when the mutant mice were 
starved (16 hours) the number and the size of the GFPs were dramatically higher than the 
fasted WT animals. We suspect that the increased number of the autophagosomes in the 
lipin1 deficient mice was due to a defect in the mitophagy. The mitophagy process is 
initiated; however, a blockage in the pathway led to accumulated autophagosomes in the 
cytosol. Therefore, lipin1 deficient mice had an accumulated autophagosomes in the 
cytoplasm of the EDL muscle.  
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Figure 6: The novel lipin1 deficient EGFP-LC3 transgenic mice model expresses 
endogenous GFP.  These immunofluorescent images obtained from EDL muscles from 
WT and the lipin1 deficient EGFP-LC3 mice and examined by the immunofluorescent 
microscope. The sections were only fixed and stained with DAPI. At the top, the sections 
belong to the WT mice with two conditions, basal and fasting (16 hours). Upon 16 hours 
fasting, the WT muscle showed an increased autophagosomes formation compared to the 
basal level. In the bottom the lipin1 -/- EGFP-LC3 EDL muscles also in two conditions, 
basal and fasting. The count of the GFP dots was higher in the mutant mice compared to 
the WT at the basal. However, a greater rise was observed in the fasting lipin1 -/- EGFP-
LC3 EDL muscles in comparison to the fasted WT mice. The magnification of these 
images is 100X.  
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2- Lipin1 deficiency induces inhibition of autophagy and mitophagy in the               
Lipin -/- EGFP-LC3 transgenic mice. 
 
        As shown in Figure 6, the mitophagy pattern was increased in the Lipin -/- 
EGFP-LC3 transgenic mice compared to the WT based on the immunofluorescent 
analysis. We wanted to confirm that the increased GFPs dots in the cytoplasm were a 
result of increased mitophagy activity. Thus, we examined the protein expression 
profiles of the mitophagy and autophagy markers LC3, p62, (Mizushima, 2015) 
Bnip3 and Parkin in the WT and Lipin -/- EGFP-LC3 transgenic mice. We obtained 
the lysates from EDL and soleus muscles from the WT and Lipin -/- EGFP-LC3 
transgenic mice collected from two conditions, basal and fasting (16 hours) (Figure 7, 
panel A). Lipin1 was only expressed in the WT muscles and totally knocked out in 
the lipin1-/- EGFP-LC3 mice. This confirmed that the genetic lipin1 knockout was 
successful in the lipin1-/- EGFP-LC3 mice. The autophagic molecule LC3 shows two 
bands in the western blot, the upper one is LC3-I and the lower one is LC3-II. The 
difference here is that LC3-I has been reported to migrates lower than the LC3-II as it 
indicated by the arrows (Figure, 7) (W. Wang, Chen, Billiar, Stang, & Gao, 2013). At 
the basal level, the autophagic marker LC3II (the lower band) expression was raised 
in the mutant versus the WT.  On the other hand, in response to fasting LC3II protein 
expression was increased by two fold compared to the basal and the rest of the 
conditions in the EDL muscle of the mutant mice. Upon stressing the cells with serum 
starvation, autophagy was upregulated to balance the energy by recycling some of the 
cytoplasmic content. The mitochondrial damage markers were examined too. Bnip3 
of the EDL muscle was upregulated in the Lipin1-/- EGFP-LC3 at the basal level. 
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Moreover, Bnip3 was further raised in response to nutrient withdrawal in the mutant 
as the expression profile revealed (Figure 7, A). Upregulation of Bnip3 protein 
suggests that the defective mitophagy in the EDL of the lipin1 deficient EGFP-LC3 
mice was mediated by Bnip3 in this context. Similar to a previous report (Howells et 
al., 1978)  the EDL muscle presented a greater response for fasting in comparison to 
the soleus (check introduction, EDL versus soleus). The autophagic signaling 
pathways are sensitive to food withdrawal in the EDL. The other mitochondrial 
damage marker, Parkin, didn’t show significant changes in all treatments and 
conditions. Put together, lipin1 deficiency markedly activates the mitophagy in the 
skeletal muscle of the Lipin -/- EGFP-LC3 transgenic mice as the expression of major 
autophagy and mitophagy markers were elevated.  
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Figure 7: Lipin1 deficiency upregulates autophagy and mitophagy markers in the EDL 
and soleus muscles of the Lipin -/- EGFP-LC3 transgenic mice. (A) Representative 
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immunoblots of key proteins involved in autophagy and mitophagy from EDL and SOL 
muscles in WT and lipin1-/- EGFP-LC3 transgenic mice. From each mouse type, WT and 
lipin1-/- EGFP-LC3, we divided each type into basal and fasting (16h). Then mice were 
sacrificed and muscle tissue was collected for western blotting analysis. The protein 
lysates were separated on 12.5% SDS-PAGE and then immunoblotted with antibodies 
against the mitophagy markers. (B) The first chart belongs to the EDL muscle, the second 
chart belongs to soleus muscle. The basal WT was used as a control. The expression of 
the major markers was normalized to GAPDH.  Error bars represent the standard 
deviation (SD). Comparing fasting to basal condition significant changes observed in the 
EDL with (*) p-value ≤ 0.07, (**) p-value ≤ 0.08, but no significant changes in soleus. 
GAPDH was used as a loading control.  
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3- Lipin1 deficiency induces upregulation of AMPK in the Lipin-/- -EGFP-LC3 
transgenic mice. 
 
To check how lipin1 deficiency contributes to the mitophagy alteration we 
assessed the several mitophagy activation signaling pathways and examined the protein 
expression of potential molecules that may have a role in the defective mitophagy. Based 
on literature, the expression level of FOXO3 (belongs to the forkhead family of 
transcription factors) has been shown to be regulated by the AMP-activated protein 
kinase (AMPK) (Greer et al., 2007). FOXO3 has been shown to regulate the expression 
of LC3 and Bnip3 (Mammucari, 2007). Then we looked at the foxo3 activation by 
measuring the phosphorylated FOXO3 (s413) expression level in the lipin1-/- EGFP-LC3 
mice. The AMPK and p-FOXO3 were upregulated in the mutant mice during fasting 
status. The FOXO3 expression was higher than the control condition (Figure 8). We 
suggest that Lipin1 deficiency induced lipid or nutrient repression, which in turn activates 
AMPK, and increase its activity then upregulates FOXO3. The activated FOXO3 will 
then increase the transcription of autophagy/mitophagy markers, LC3 and Bnip3. We 
didn’t run statistics for this data to check the significance.  
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(A) 
 
 
(B) 
 
Figure 8: Lipin1 deficiency induces upregulation of AMPK in the Lipin-/- -EGFP-LC3 
transgenic mice: (A) Western blotting of the potential proteins involved in dysfunctional 
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mitophagy in the lipin1-/- -EGFP-LC3 transgenic mice. WT and lipin1-/- -EGFP-LC3 
transgenic mice were restricted from food for 16 hours followed by muscle tissue 
collection. The EDL was homogenized and protein lysate was collected for resolving by 
7.5% SDS-PAGE gel. The separated proteins were probed with AMPK and p-FOXO3 
(s413) antibodies.  The AMPK and FOXO3 were activated in the lipin1-/- -EGFP-LC3 
transgenic mice. (B) The expression of the AMPK and FOXO3 was normalized to 
GAPDH. The error bars represent the SD. GAPDH was used as a loading control.  
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4- Moderate elevation in the gene transcription activity of the mitophagy 
markers of the lipin1-/- -EGFP-LC3 mice: 
The protein expression of the mitophagy markers were elevated in the lipin1-/- -
EGFP-LC3 animals (Figure 7). So, we want to measure the transcriptional activity of the 
autophagy/mitophagy markers to test whether the increased expression in the cytosol was 
due to increased gene transcription or not. The EDL muscle was collected from WT and 
lipin1-/- -EGFP-LC3 from two different conditions, basal and fasting (16 hours). Then, 
the mRNA was extracted from the tissue and then we generated cDNA library. qPCR was 
performed to obtain the quantitative analysis of the gene expression of Lipin1, LC3, p62 
and Bnip3 (Figure 9). The lipin1 gene transcription was only detected in the WT animals, 
and the mutant ones had no activity. In the fasted status, LC3 and p62 of the lipin1-/- -
EGFP-LC3 revealed a slight increase in the gene transcription activity compared to 
starved WT. For the mitophagy marker, Bnip3, of the lipin1-/- -EGFP-LC3 mice we 
detected a slight increase of the gene transcription compared to the fasted WT. These data 
suggest that the increase of the protein expressions in the cytosol of lipin1-/- -EGFP-LC3 
mice was to some extent due to increase transcription activity.  
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Figure 9: Moderate elevation in the gene transcription activity of the mitophagy 
markers of the lipin1-/- -EGFP-LC3 mice: The mRNA transcription level of the 
mitophagy markers were evaluated in the EDL muscle of the WT and lipin1-/- -EGFP-
LC3 mice. The WT and lipin1-/- -EGFP-LC3 mice each was divided into two groups 
basal and fasting (16 hours). Then, the EDL muscle were harvested and digested to 
extract the RNA. cDNA library was generated and qPCR result were obtained from the 
different groups mice. We examined the gene transcription level of the Lipin1, LC3, p62 
and Bnip3. Error bars represent the SD.  
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Aim 2: To visualize the effect of lipin1 deficiency on mitophagy process using 
Lipin1-/- -EGFP-LC3 transgenic mice. 
Aim 3: To determine whether the improvement of mitochondrial membrane 
potential could ameliorate Lipin1-associated mitophagy defects. 
 
5- Cyclosporine A ameliorated lipin1 deficient induced mitophagic defect in the  
EDL muscle: 
 
In Figure 7 the mitophagy markers were increased in the lipin1-/- -EGFP-LC3 
transgenic mice; therefore, we want to treat the mice either to inhibit mitophagy, or 
improve mitochondrial function and reduce mitophagy activity. Thus, we injected the 
WT and Lipin1-/- -EGFP-LC3 transgenic mice with Chloroquine diphosphate (CD) and 
cyclosporine A (CsA) then collected the EDL muscles. The CD considered as a 
mitophagy blocker where the mitophagy process is initiated but is not completed (Yoon 
et al., 2010). The CsA has been shown to improve mitochondrial membrane potential via 
preventing the mitochondria permeability transition (MPT) (Fournier, Ducet, & Crevat, 
1987). The animals were injected for 10 days followed with 16 hours of fasting (as 
described in methods). The collected EDL muscles were used for western blotting 
experiment (Figure 10). We once more looked at the protein expressions of 
autophagy/mitophagy markers by resolving them with 12.5% SDS-PAGE gel.  In fasting 
status, similar to what we observed in figure 7, LC3 was upregulated in lipin1-/- -EGFP-
LC3 mice compared to WT. Same scenario happened to Bnip3, and its expression was 
increased in the lipin1-/- -EGFP-LC3 samples versus the WT. The upregulation of these 
markers was due to fasting, which induces the autophagy machinery to provide energy to 
the cell. The next group is the CD treated animals. Since the CD inhibits mitophagy we 
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saw similar expression of LC3 in both WT and lipin1-/- -EGFP-LC3 due to blocking the 
clearance process in both groups as it is highlighted in a red box (Figure 10). In the case 
of Bnip3, the mitochondrial damage marker, the protein was upregulated only in the lipin-
/- -EGFP-LC3 mice as the blots show (Figure 10). This result suggested that the defective 
mitophagy in lipin1-/- -EGFP-LC3 animals was mediated by the Bnip3 pathway. On the 
other hand, Parkin didn’t show any significant response in this context. To test whether 
improving mitochondrial function may facilitate the impaired mitophagy, the mice were 
injected with CsA for 10 days followed by 16 hours of fasting. The autophagy markers’ 
expressions were evaluated by western blotting (Figure 10). In response to CsA treatment 
LC3 showed a basal level similar to the WT basal condition, which revealed an effective 
CsA treatment on ameliorating mitophagy process. The downregulation of LC3 
expression was detected in both WT and lipin1-/- -EGFP-LC3. Moreover, the Bnip3 was 
downregulated in the WT and lipin1-/- -EGFP-LC3 mice. These results suggest that CsA 
treatment rescued the defect in the mitophagy which resulted from lipin1 deficiency.   
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(B) 
 
41 
 
Figure 10: Cyclosporine A treatment ameliorated the defective mitophagy due to lipin1 
deficiency in EDL muscle of the WT and the lipin1-/- -EGFP-LC3 mice. (A) These 
western blots show several autophagy/ mitophagy markers. The EDL muscles were 
collected from four different groups of conditions: basal, fasting, CD treated and CsA 
treated mice groups, as it appears in the top of the blots. In the fasting group, the mice were 
exposed for 16 hours of fasting then euthanized. In the CD treated group, the animal were 
injected with CD for 10 days followed by 16 hours of fasting then mice were sacrificed. 
The mice of the CsA group were injected with CsA for 10 days followed by 16 hours of 
fasting then mice were euthanized. Each group contained two subgroups, WT and lipin1-/- 
-EGFP-LC3 mice. The protein lysates were separated using 12.5% SDS-PAGE gel and 
blotted with antibodies against mitophagy markers LC3, p62, Bnip3 and Parkin. (B) The 
expression of the major markers was normalized to GAPDH. The basal WT was used as a 
control. The error bars represent the SD. Significant changes with p ≤ 0.05 are indicated 
with an asterisk compared to WT in fasting state. GAPDH was used as a loading control. 
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6- Impaired mitophagy was recovered as a response to CsA treatment in the 
EDL muscular tissue of the lipin1-/- -EGFP-LC3 mice: 
The impaired mitophagy process was ameliorated upon treatment with CsA 
according to the protein expression profiles of the lipin1-/-EGFP-LC3 mice (Figure 10). 
So, we want to confirm that by examining the EDL tissue with an immunofluorescent 
microscope and looking for GFPs dot which represent the LC3 protein that is related to 
autophagosomes’ abundance (Figure 6). We obtained cryosections from the EDL muscles 
from different treated groups of mice (as details shown in Figure 10) to examine the 
autophagosomes’ formation in the lipin1-/- -EGFP-LC3 mice (Figure 11). Those sections 
were only stained with DAPI and fixed with paraformaldehyde. Upon fasting for 16 
hours, the GFP dots were increased in the WT (Figure 11 top panel) which is an 
indication of increased autophagy rate to compensate for the nutrient deficient status. In 
the lipin1-/-EGFP-LC3 mice (Figure 11 lower panel) the GFP punctates were increased in 
both number and size compared to the WT. In the case of CD treatment, since the 
mitophagy was blocked, both WT and lipin1-/- -EGFP-LC3 mice showed almost similar 
increased pattern of GFP dots with a little bit of increase in the mutant mice. 
Interestingly, the CsA agent was able to decrease the number of GFP dots in the lipin1-/- -
EGFP-LC3 mice EDL tissue suggesting that improving mitochondrial membrane 
potential rescued the autophagy defect caused by lipin1 deficiency. This suggests that 
ameliorating mitochondrial function would result in improved mitophagy process and 
reduced the autophagosomes formation in the cytoplasm.     
43 
 
 
Figure 11: Impaired mitophagy was recovered as a response to CsA treatment in the 
EDL muscular tissue of the lipin1-/- -EGFP-LC3 mice: These immunofluorescent 
images are collected from different treatments of the EDL muscles of WT and lipin1-/- -
EGFP-LC3 mice. These sections are only stained with DAPI and fixed by 4% 
formaldehyde. The mice were divided into 3 groups: fasting, CD and CsA treated mice. 
Each group involved WT and lipin1-/- -EGFP-LC3 subjects. In the fasting group, the 
animals were only restricted from food for 16 hours but they had access to water, then 
mice were euthanized and tissue was collected. For the CD (mitophagy inhibitor) injected 
group, WT and lipin1-/- -EGFP-LC3 mice were injected for 10 days followed with fasting 
for 16 hours then EDL was harvested from both. For both WT and lipin1-/- -EGFP-LC3 
mice the count of GFP punctates was almost similar. The last two groups of mice were 
injected with CsA for 10 days and followed by fasting (16 hours) then muscle tissue was 
collected from both. In the two examined groups of animals both showed lower numbers 
of GFPs expressed in the cytoplasm.  The magnification of these images is 40X.  
44 
 
7-     The defective mitophagy caused by lipin1 deficiency is mediated by Bnip3 
pathway:  
As the immunoblotting data (Figure 10) revealed, Bnip3 (the mitochondrial 
damage marker) showed significant accumulation in the lipin1-/- -EGFP-LC3 mice. Thus, 
we wanted to confirm that observation and also see whether Bnip3 interacts and co-
localizes with LC3 protein or not with immunofluorescent staining. So, the EDL muscles 
of WT and lipin1-/- -EGFP-LC3 mice were immunostained with an antibody against 
Bnip3 protein and visualized by an immunofluorescent microscope to examine the co-
localization of the LC3-GFP and Bnip3. Indeed, we found that Bnip3 proteins were co-
localized with some of the LC3 proteins in the cytosol (Figure 12, panel A). The 
cryosections which have been stained with Bnip3 antibody are obtained from the same 
groups used in Figure 11. In the fasting group, the WT showed a high number of GFPs 
with around 35% co-localization of Bnip3. In the lipin1-/- -EGFP-LC3 mice, the number 
of GFPs and co-localizations were higher than the WT (Figure 12, panel A). The increase 
of GFPs was a result of the impaired mitophagy. When the mitophagy was inhibited by 
CD, the two groups of mice presented increased number of GFPs with more than 40% co-
localized Bnip3. The Bnip3 co-localization was higher than the WT as the quantification 
analysis revealed (Figure 12, panel B). Interestingly, when the mice were treated with 
CsA, the GFPs and Bnip3 cytosolic expression dramatically decreased in both WT and 
lipin1-/- -EGFP-LC3 mice (Figure 12, panel A). The decrease in the GFPs is a 
representative of a reduction in autophagosomes abundance in the CsA treated animals. 
This is also consistent with the western blotting data (Figure 10) where the LC3 and 
Bnip3 expression reduced in response to CsA treatment. Since CsA increases 
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mitochondrial membrane potential, it is possible that the CsA restored the defect in 
mitophagy caused by lipin1 deficiency and decreased the autophagosomes population 
which are required to eliminate the dysfunctional mitochondria. These observations are 
consistent with proteins expression profiles of LC3 and Bnip3 (Figure 10) suggesting a 
direct interaction and co-localization of Bnip3 with LC3. The number of GFPs were 
counted in the fasting, CsA and CD groups as is shown in (Figure 12, panel B). The GFPs 
and Bnip3 counting included 10 different fields from each group (Figure 12, panel B top 
chart) and then the Bnip3 was normalized to total GFPs as it shown in (Figure 12, panel 
B lower chart).  
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Figure 12: The defective mitophagy caused by lipin1 deficiency is mediated by Bnip3 
pathway: The EDL muscle sections of the WT and lipin1-/- -EGFP-LC3 mice were only 
immunostained with Bnip3 antibody to examine its co-localization with GFP-LC3 
protein. (A) In the fasted group, WT and mutant mice were fasted for 16 hours then 
WT 
Lipin1 -/- 
Lipin1 -/- 
WT 
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sacrificed. EDL muscle was collected and cut in to thin sections (5-7 u) and then 
immunostained with Bnip3 antibody. The lipin1-/- -EGFP-LC3 mice presented a much 
higher number of GFPs and Bnip3 co-localized together compared to the WT (the top 
two panels). In the CD treated group, animals were injected with CD for 10 days, then 
followed by starvation 16 hours. The EDL was collected and cut into thin sections and 
stained with only Bnip3 antibody. Due to the effect of the drug both WT and lipin1-/- -
EGFP-LC3 muscles showed increased number of GFPs and Bnip3 with more GFPs 
abundance in the mutant animals than WT. In contrast, CsA treated mice were also 
injected for 10 days with CsA and then fasted for 16 hours. Then we did similar 
procedure followed with the CD group. CsA Treatment was effective in ameliorating the 
mitochondrial dysfunction and therefore decreased the GFPs and Bnip3 expressions in 
both WT and lipin1-/- -EGFP-LC3 as it shown in the lower two panels. (B) The number of 
the GFPs were quantified from 10 different fields for each group (the top chart). The ratio 
of Bnip3 co-localized to GFP-LC3 was also calculated as it shows in the lower chart.  
The error bars represent SD. Significant changes with p-value < 0.002 compared to 
fasting state.  
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IV- Discussion 
 
Mitochondrial clearance (mitophagy) is one of the fundamental processes within 
eukaryotic cells. Its role is to assess mitochondrial population integrity and eliminate 
dysfunctional ones from the cytosol (Yoshii & Mizushima, 2015). Several serious 
illnesses have been associated with defective mitophagy such as Parkinson's disease, 
cardiovascular diseases and neurodegenerative disorders (Kanki et al., 2015; Redmann et 
al., 2014). Phosphatidic acid phosphatase, also called lipin1, is involved in phospholipids’ 
and triglycerides’ metabolism and also acts as a transcriptional co-activator regulating the 
fatty acid oxidation and lipogenesis (Y. Chen et al., 2015).  Lipin1 has been found to be 
mutated in muscular tissue obtained from patients with severe rhabdomyolysis (Zeharia 
et al., 2008). These patients also exhibited with aggregated and dysfunctional 
mitochondria in their type II muscle fibers. From a previous work we have done, electron 
microscope imaging revealed that mice with lipin1 knockout had aggregated 
mitochondrial accompanied with abnormal autophagosomes formations in the glycolytic 
muscle sections. We thought that there is a link between impaired mitophagy and 
mitochondrial functions, and lipin1 deficiency in skeletal muscle. Taken together, lipin1 
deficiency may be involved in promoting dysfunctional mitochondria and defective 
mitophagy in skeletal muscles, which in turn leads to muscle atrophy.    
The need to find approaches to study the mitophagy and mitochondrial function in 
vivo is necessary in terms of providing more specific and reliable tools. So, we generated 
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a mice model to examine the mitochondrial autophagy in skeletal muscles. The unique 
model is called lipin1-/- -EGFP-LC3 transgenic mice (see methods), which expresses 
green fluorescent protein (GFP) along with microtubule-associated light chain 3(LC3) 
protein, which decorates the autophagosome surface. This mice model allowed us to 
visualize autophagic vacuoles by looking for GFPs in the cytosol (Figure 6) of the 
muscle cryosections, as has been used commonly (Mizushima & Kuma, 2008).   
Two different muscles fibers where the dysregulated mitophagy has been 
examined in our study, glycolytic fibers, which is a major component in Extensor 
Digitorum Longus (EDL) and oxidative fiber, such as soleus. Based on the difference in 
the muscle atrophy and autophagy activations pathways in these two different muscles, 
we looked at different responses of the EDL and soleus muscles obtained from lipin1-/- -
EGFP-LC3 transgenic mice during starvation. Upon fasting the autophagy seemed to be 
more pronounced in the EDL versus soleus (Howells et al., 1978). Soleus has a higher 
expression of PGC1α which protects the oxidative muscle from atrophy by inhibiting 
activity of FOXO3 (Yamada et al., 2012). In contrast to the oxidative fibers, PGC1α is 
reduced in the glycolytic fibers which leads to increased activity of FOXO3 and then 
upregulates autophagy. Several pathways are known to influence the glycolytic muscle 
fiber during fasting and control muscle mass by regulating protein degradation and 
autophagy, such as Forkhead box O family (Foxo), transforming growth factor beta 
(TGFβ) family, autophagy inhibition, and nuclear factor kappaB (NF-κB) (Y. Wang & 
Pessin, 2013). FOXO3 and autophagy gene mutations have been implicated in altering 
muscle mass and autophagy (see introduction). Another paper started that the EDL is 
more vulnerable to initiates mitophagy than soleus by inhibiting autophagy-related 
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molecules (Yamada et al., 2012). This feature is very valuable for us as it facilitates the 
study of mitophagy in skeletal muscles and monitors its regulation and activation. 
 Not only autophagy markers found to present a significant changes in EDL, also 
mitochondrial damage markers were upregulated too in the lipin1-/- -EGFP-LC3 
transgenic mice such as Bnip3 (Figure, 7). Several mitochondrial damage markers have 
been established in literature, we have looked at major pathways and their markers in a 
previous study and we reported that only Bnip3 was increased in the lipin1 deficient 
mice. We also looked at the expression profile of Parkin (a mitochondrial damage 
marker) and we found no significant response was observed in lipin1-/- -EGFP-LC3 
transgenic mice. Therefore, we speculate that the defective mitophagy seen in this new 
mice model was mediated by Bnip3 pathway. The role of Bnip3 has been controversial 
among investigators (Vasagiri & Kutala, 2014). Many studies found that Bnip3 was 
activated in hypoxic condition and then upregulates autophagy (Guo et al., 2001). Other 
studies revealed that Bnip3 overexpression contributed to the mitochondrial dysfunction 
by increasing the mitochondrial permeability transition (MPT) pore opening, also leads to 
mitochondrial fragmentation/fission (Kubasiak, Hernandez, Bishopric, & Webster, 2002; 
Landes et al., 2010; Vande Velde et al., 2000). Bnip3 role in activation mitophagy can be 
elucidated by the following potential mechanism (Ney, 2015); 1) Bnip3 causes 
mitochondrial dysfunctional via increased production of ROS, which then activates 
autophagy (Scherz-Shouval & Elazar, 2011). 2) Bnip3 can suppress mTOR by binding to 
Rheb (an activator of mTOR) and upregulates the autophagy (Li et al., 2007). The first 
mechanism is consistent with our results especially during fasting where we observed a 
dramatic elevated expression of Bnip3 in the lipin1-/- -EGFP-LC3 transgenic mice, which 
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leads to dysfunctional mitophagy. We may suggest that increased Bnip3 expression leads 
to elevated ROS which in turn causes a mitochondrial damage.  
Altered mitochondrial membrane potential leads to induction of damage signals 
and then activates mitophagy. When mitochondria are depolarized, fission and fusion 
events are disrupted, which eventually affects the mitochondrial function and they are not 
able to produce enough ATPs to meet cellular demands (Matsuda et al., 2010; Twig et al., 
2008). This leads to activate mitophagy and eliminate these damaged organelles. 
Promoting the mitochondrial membrane potential by some drugs would enhance the 
performance of dysfunctional mitochondria. We treated the WT and lipin1-/- -EGFP-LC3 
transgenic mice with a mitophagy inhibitor Chloroquine diphosphate (CQ) and with an 
agent which increases the mitochondrial membrane potential, Cyclosporine A (CsA), 
then monitor the mitophagy rate in these two groups (De Palma et al., 2014; Merlini et 
al., 2008; Muratsubaki et al., 2017). CQ inhibited the mitophagy in EDL muscle of WT 
and lipin1-/- -EGFP-LC3 transgenic mice. LC3 and Bnip3 were both upregulated in WT 
and lipin1-/- -EGFP-LC3 transgenic mice as we detected that in western blotting and 
immunofluorescent imaging (Figures, 10 and 12). On the other hand, mice injected with 
CsA, their EDL demonstrated a dramatic decrease in autophagy markers, which might be 
due to improved mitochondrial function and subsequently the mitophagy was decreased 
in both WT and lipin1-/- -EGFP-LC3 transgenic mice as we analyzed the samples with 
immunoblotting and immunostaining (Figures 10 and 12) .  The enhanced mitochondrial 
function with CsA treatment (Bunger, 2013) was robust in the skeletal muscle of the mice 
with lipin1 deficiency suggesting a new therapeutic approach for patients with muscle 
atrophy.    
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The autophagy marker, LC3, requires molecules to act as adaptors to facilitate the 
interaction between LC3 and engulfed material. One of the common autophagy adaptors 
is p62/SQSTM1 which is essential for engulfment of the cytoplasmic components by the 
autophagosomes (Pankiv et al., 2007). In mitochondrial autophagy, some of the major 
mitochondrial damage markers don’t required p62 binding to mitochondria to be 
engulfed, they rather interact with LC3 directly such as Bnip3.  Bnip3 possess an LC3 
interacting region (LIR) which allows the molecule to interact with LC3 then facilitates 
the engulfment (Hanna et al., 2012). We found that protein expression of Bnip3 was 
increased in the mutant mice (Figure, 10). We further examine whether Bnip3 co-
localized with LC3 or not by immunofluorescent staining. The Immunofluorescent 
imaging revealed that Bnip3 co- localized with LC3 in the EDL muscle of the lipin1-/- -
EGFP-LC3 transgenic mice suggesting a direct interaction of Bnip3 with LC3 which is 
consistent with published studies in literature(Figure, 12) (Hanna et al., 2012).  
One potential mechanism where lipin1 deficiency may play a role in defective 
mitophagy is through altering the mitochondrial lipid composition. As mentioned before, 
lipin1 converts PA into DAG on the mitochondrial outer membrane. DAG and PA have 
been shown to be essential for fission and fusion processes (H. Chen et al., 2003; Ha & 
Frohman, 2014; Huang et al., 2011). Since, lipin1 function is impaired in the lipin1-/- -
EGFP-LC3 transgenic mice, this led to abnormal lipids composition of mitochondria and 
affects the fission/fusion steps then subsequently causes dysfunctional mitophagy. 
To further elucidate the role of lipin1 deficiency on impaired mitophagy we 
looked at the major mitophagy activation pathways. From literature we found that during 
food depletion regulation of LC3 and Bnip3 genes transcription was through FOXO3 
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(Mammucari et al., 2007). During fasting, AMPK upregulates FOXO3 (Bujak et al., 
2015) and allow its translocation to the nucleus to activate the transcription of the 
autophagy/mitophagy molecules (Figure, 8). Based on that, we suggest that lipin1 
deficiency induced nutrients imbalance which in turn activates AMPK and subsequently 
leads to increase expression of LC3 and Bnip3 genes. This continuous mitophagy 
activation results in breaking down the muscular tissue and eventually causes muscle 
atrophy. So, we attributed the increased LC3 and Bnip3 in the cytosol in the lipin1-/- -
EGFP-LC3 transgenic mice was partially due to FOXO3 activation. However, we don’t 
rule out the possibility that the accumulated proteins in the cytoplasm was due to 
mitophagy blockage.  
In conclusion, our study suggests the mechanism by which lipin1 deficiency 
contributes to the skeletal muscle dysregulated mitophagy and atrophy. Moreover, we 
demonstrated that the transcriptional factor FOXO3 was upregulated in the lipin1-/- -
EGFP-LC3 transgenic mice which can be used a therapeutic approach to reduce 
mitophagy rate in the skeletal muscle. For future studies, we want to examine 1) how 
lipin1 deficiency leads to protein degradation; 2) identify whether lipin1 plays any role in 
mitophagy/lysosomal degradation process; 3) assess mitochondrial membrane lipid 
composition to understand the effect of lipin1 deficiency.  
 
  
55 
 
 
 
References  
Alirezaei, M., Kemball, C. C., Flynn, C. T., Wood, M. R., Whitton, J. L., & Kiosses, W. 
B. (2010). Short-term fasting induces profound neuronal autophagy. Autophagy, 
6(6), 702-710.  
Ban, T., Ishihara, T., Kohno, H., Saita, S., Ichimura, A., Maenaka, K., . . . Ishihara, N. 
(2017). Molecular basis of selective mitochondrial fusion by heterotypic action 
between OPA1 and cardiolipin. Nat Cell Biol, 19(7), 856-863. 
doi:10.1038/ncb3560 
Brand, M. D., & Nicholls, D. G. (2011). Assessing mitochondrial dysfunction in cells. 
Biochem J, 435(2), 297-312. doi:10.1042/BJ20110162 
Bujak, A. L., Crane, J. D., Lally, J. S., Ford, R. J., Kang, S. J., Rebalka, I. A., . . . 
Steinberg, G. R. (2015). AMPK activation of muscle autophagy prevents fasting-
induced hypoglycemia and myopathy during aging. Cell Metab, 21(6), 883-890. 
doi:10.1016/j.cmet.2015.05.016 
Cai, Q., & Tammineni, P. (2016). Alterations in Mitochondrial Quality Control in 
Alzheimer's Disease. Front Cell Neurosci, 10, 24. doi:10.3389/fncel.2016.00024 
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003). 
Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are 
essential for embryonic development. J Cell Biol, 160(2), 189-200. 
doi:10.1083/jcb.200211046 
Chen, Y., Rui, B. B., Tang, L. Y., & Hu, C. M. (2015). Lipin family proteins--key 
regulators in lipid metabolism. Ann Nutr Metab, 66(1), 10-18. 
doi:10.1159/000368661 
Chu, C. T., Ji, J., Dagda, R. K., Jiang, J. F., Tyurina, Y. Y., Kapralov, A. A., . . . Kagan, 
V. E. (2013). Cardiolipin externalization to the outer mitochondrial membrane 
acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol, 
15(10), 1197-1205. doi:10.1038/ncb2837 
Cuervo, A. M. (2004). Autophagy: in sickness and in health. Trends Cell Biol, 14(2), 70-
77. doi:10.1016/j.tcb.2003.12.002 
56 
 
Cullis, P. R., Hope, M. J., & Tilcock, C. P. (1986). Lipid polymorphism and the roles of 
lipids in membranes. Chem Phys Lipids, 40(2-4), 127-144.  
De Palma, C., Morisi, F., Cheli, S., Pambianco, S., Cappello, V., Vezzoli, M., . . . 
Clementi, E. (2014). Autophagy as a new therapeutic target in Duchenne 
muscular dystrophy. Cell Death Dis, 5, e1363. doi:10.1038/cddis.2014.312 
Detmer, S. A., Vande Velde, C., Cleveland, D. W., & Chan, D. C. (2008). Hindlimb gait 
defects due to motor axon loss and reduced distal muscles in a transgenic mouse 
model of Charcot-Marie-Tooth type 2A. Hum Mol Genet, 17(3), 367-375. 
doi:10.1093/hmg/ddm314 
Donkor, J., Zhang, P., Wong, S., O'Loughlin, L., Dewald, J., Kok, B. P., . . . Reue, K. 
(2009). A conserved serine residue is required for the phosphatidate phosphatase 
activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J 
Biol Chem, 284(43), 29968-29978. doi:10.1074/jbc.M109.023663 
Fournier, N., Ducet, G., & Crevat, A. (1987). Action of cyclosporine on mitochondrial 
calcium fluxes. J Bioenerg Biomembr, 19(3), 297-303.  
Gomes, L. C., & Scorrano, L. (2013). Mitochondrial morphology in mitophagy and 
macroautophagy. Biochim Biophys Acta, 1833(1), 205-212. 
doi:10.1016/j.bbamcr.2012.02.012 
Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P., & 
Brunet, A. (2007). The energy sensor AMP-activated protein kinase directly 
regulates the mammalian FOXO3 transcription factor. J Biol Chem, 282(41), 
30107-30119. doi:10.1074/jbc.M705325200 
Guo, K., Searfoss, G., Krolikowski, D., Pagnoni, M., Franks, C., Clark, K., . . . 
Ivashchenko, Y. (2001). Hypoxia induces the expression of the pro-apoptotic 
gene BNIP3. Cell Death Differ, 8(4), 367-376. doi:10.1038/sj.cdd.4400810 
Ha, E. E., & Frohman, M. A. (2014). Regulation of mitochondrial morphology by lipids. 
Biofactors, 40(4), 419-424. doi:10.1002/biof.1169 
Hanna, R. A., Quinsay, M. N., Orogo, A. M., Giang, K., Rikka, S., & Gustafsson, A. B. 
(2012). Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 
protein to selectively remove endoplasmic reticulum and mitochondria via 
autophagy. J Biol Chem, 287(23), 19094-19104. doi:10.1074/jbc.M111.322933 
Harris, T. E., Huffman, T. A., Chi, A., Shabanowitz, J., Hunt, D. F., Kumar, A., & 
Lawrence, J. C., Jr. (2007). Insulin controls subcellular localization and multisite 
57 
 
phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem, 
282(1), 277-286. doi:10.1074/jbc.M609537200 
Howells, K. F., Jordan, T. C., & Mathews, D. R. (1978). Effects of pre- and perinatal 
undernutrition on muscle fibre and function in fast and slow rat muscles 
[proceedings]. Proc Nutr Soc, 37(3), 112A.  
Huang, H., Gao, Q., Peng, X., Choi, S. Y., Sarma, K., Ren, H., . . . Frohman, M. A. 
(2011). piRNA-associated germline nuage formation and spermatogenesis require 
MitoPLD profusogenic mitochondrial-surface lipid signaling. Dev Cell, 20(3), 
376-387. doi:10.1016/j.devcel.2011.01.004 
Huttemann, M., Lee, I., Pecinova, A., Pecina, P., Przyklenk, K., & Doan, J. W. (2008). 
Regulation of oxidative phosphorylation, the mitochondrial membrane potential, 
and their role in human disease. J Bioenerg Biomembr, 40(5), 445-456. 
doi:10.1007/s10863-008-9169-3 
James, R. S., Altringham, J. D., & Goldspink, D. F. (1995). The mechanical properties of 
fast and slow skeletal muscles of the mouse in relation to their locomotory 
function. J Exp Biol, 198(Pt 2), 491-502.  
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., . . . 
Yoshimori, T. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized 
in autophagosome membranes after processing. EMBO J, 19(21), 5720-5728. 
doi:10.1093/emboj/19.21.5720 
Kanki, T., Furukawa, K., & Yamashita, S. (2015). Mitophagy in yeast: Molecular 
mechanisms and physiological role. Biochim Biophys Acta, 1853(10 Pt B), 2756-
2765. doi:10.1016/j.bbamcr.2015.01.005 
Kim, M. S., Jeong, E. G., Ahn, C. H., Kim, S. S., Lee, S. H., & Yoo, N. J. (2008). 
Frameshift mutation of UVRAG, an autophagy-related gene, in gastric 
carcinomas with microsatellite instability. Hum Pathol, 39(7), 1059-1063. 
doi:10.1016/j.humpath.2007.11.013 
Kluge, M. A., Fetterman, J. L., & Vita, J. A. (2013). Mitochondria and endothelial 
function. Circ Res, 112(8), 1171-1188. doi:10.1161/CIRCRESAHA.111.300233 
Kubasiak, L. A., Hernandez, O. M., Bishopric, N. H., & Webster, K. A. (2002). Hypoxia 
and acidosis activate cardiac myocyte death through the Bcl-2 family protein 
BNIP3. Proc Natl Acad Sci U S A, 99(20), 12825-12830. 
doi:10.1073/pnas.202474099 
58 
 
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., . . . 
Mizushima, N. (2004). The role of autophagy during the early neonatal starvation 
period. Nature, 432(7020), 1032-1036. doi:10.1038/nature03029 
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. 
(1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Res, 
19(15), 4293.  
Landes, T., Emorine, L. J., Courilleau, D., Rojo, M., Belenguer, P., & Arnaune-
Pelloquin, L. (2010). The BH3-only Bnip3 binds to the dynamin Opa1 to promote 
mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep, 
11(6), 459-465. doi:10.1038/embor.2010.50 
Levine, B., & Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell, 
132(1), 27-42. doi:10.1016/j.cell.2007.12.018 
Li, Y., Wang, Y., Kim, E., Beemiller, P., Wang, C. Y., Swanson, J., . . . Guan, K. L. 
(2007). Bnip3 mediates the hypoxia-induced inhibition on mammalian target of 
rapamycin by interacting with Rheb. J Biol Chem, 282(49), 35803-35813. 
doi:10.1074/jbc.M705231200 
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & 
Levine, B. (1999). Induction of autophagy and inhibition of tumorigenesis by 
beclin 1. Nature, 402(6762), 672-676. doi:10.1038/45257 
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., . . . 
Sandri, M. (2007). FoxO3 controls autophagy in skeletal muscle in vivo. Cell 
Metab, 6(6), 458-471. doi:10.1016/j.cmet.2007.11.001 
Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., . . . Tanaka, K. 
(2010). PINK1 stabilized by mitochondrial depolarization recruits Parkin to 
damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol, 
189(2), 211-221. doi:10.1083/jcb.200910140 
Merlini, L., Angelin, A., Tiepolo, T., Braghetta, P., Sabatelli, P., Zamparelli, A., . . . 
Bernardi, P. (2008). Cyclosporin A corrects mitochondrial dysfunction and 
muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci U S 
A, 105(13), 5225-5229. doi:10.1073/pnas.0800962105 
Michot, C., Hubert, L., Romero, N. B., Gouda, A., Mamoune, A., Mathew, S., . . . de 
Lonlay, P. (2012). Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and 
exercise-induced myalgia. J Inherit Metab Dis, 35(6), 1119-1128. 
doi:10.1007/s10545-012-9461-6 
59 
 
Mizushima, N. (2004). Methods for monitoring autophagy. Int J Biochem Cell Biol, 
36(12), 2491-2502. doi:10.1016/j.biocel.2004.02.005 
Mizushima, N., & Kuma, A. (2008). Autophagosomes in GFP-LC3 Transgenic Mice. 
Methods Mol Biol, 445, 119-124. doi:10.1007/978-1-59745-157-4_7 
Mizushima, N., Yoshimori, T., & Ohsumi, Y. (2011). The role of Atg proteins in 
autophagosome formation. Annu Rev Cell Dev Biol, 27, 107-132. 
doi:10.1146/annurev-cellbio-092910-154005 
Muratsubaki, S., Kuno, A., Tanno, M., Miki, T., Yano, T., Sugawara, H., . . . Miura, T. 
(2017). Suppressed autophagic response underlies augmentation of renal 
ischemia/reperfusion injury by type 2 diabetes. Sci Rep, 7(1), 5311. 
doi:10.1038/s41598-017-05667-5 
Narendra, D., Tanaka, A., Suen, D. F., & Youle, R. J. (2008). Parkin is recruited 
selectively to impaired mitochondria and promotes their autophagy. J Cell Biol, 
183(5), 795-803. doi:10.1083/jcb.200809125 
Ney, P. A. (2015). Mitochondrial autophagy: Origins, significance, and role of BNIP3 
and NIX. Biochim Biophys Acta, 1853(10 Pt B), 2775-2783. 
doi:10.1016/j.bbamcr.2015.02.022 
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J. A., Outzen, H., . . . Johansen, 
T. (2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of 
ubiquitinated protein aggregates by autophagy. J Biol Chem, 282(33), 24131-
24145. doi:10.1074/jbc.M702824200 
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., 
. . . Sabatini, D. M. (2011). mTOR complex 1 regulates lipin 1 localization to 
control the SREBP pathway. Cell, 146(3), 408-420. 
doi:10.1016/j.cell.2011.06.034 
Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., . . . Plotz, P. (2008). 
Suppression of autophagy in skeletal muscle uncovers the accumulation of 
ubiquitinated proteins and their potential role in muscle damage in Pompe disease. 
Hum Mol Genet, 17(24), 3897-3908. doi:10.1093/hmg/ddn292 
Redmann, M., Dodson, M., Boyer-Guittaut, M., Darley-Usmar, V., & Zhang, J. (2014). 
Mitophagy mechanisms and role in human diseases. Int J Biochem Cell Biol, 53, 
127-133. doi:10.1016/j.biocel.2014.05.010 
60 
 
Ren, M., Phoon, C. K., & Schlame, M. (2014). Metabolism and function of mitochondrial 
cardiolipin. Prog Lipid Res, 55, 1-16. doi:10.1016/j.plipres.2014.04.001 
Romanello, V., & Sandri, M. (2015). Mitochondrial Quality Control and Muscle Mass 
Maintenance. Front Physiol, 6, 422. doi:10.3389/fphys.2015.00422 
Saraste, M. (1999). Oxidative phosphorylation at the fin de siecle. Science, 283(5407), 
1488-1493.  
Scherz-Shouval, R., & Elazar, Z. (2011). Regulation of autophagy by ROS: physiology 
and pathology. Trends Biochem Sci, 36(1), 30-38. doi:10.1016/j.tibs.2010.07.007 
Suviolahti, E., Reue, K., Cantor, R. M., Phan, J., Gentile, M., Naukkarinen, J., . . . 
Peltonen, L. (2006). Cross-species analyses implicate Lipin 1 involvement in 
human glucose metabolism. Hum Mol Genet, 15(3), 377-386. 
doi:10.1093/hmg/ddi448 
Twig, G., Elorza, A., Molina, A. J., Mohamed, H., Wikstrom, J. D., Walzer, G., . . . 
Shirihai, O. S. (2008). Fission and selective fusion govern mitochondrial 
segregation and elimination by autophagy. EMBO J, 27(2), 433-446. 
doi:10.1038/sj.emboj.7601963 
Vande Velde, C., Cizeau, J., Dubik, D., Alimonti, J., Brown, T., Israels, S., . . . 
Greenberg, A. H. (2000). BNIP3 and genetic control of necrosis-like cell death 
through the mitochondrial permeability transition pore. Mol Cell Biol, 20(15), 
5454-5468.  
Vasagiri, N., & Kutala, V. K. (2014). Structure, function, and epigenetic regulation of 
BNIP3: a pathophysiological relevance. Mol Biol Rep, 41(11), 7705-7714. 
doi:10.1007/s11033-014-3664-x 
Wang, W., Chen, Z., Billiar, T. R., Stang, M. T., & Gao, W. (2013). The carboxyl-
terminal amino acids render pro-human LC3B migration similar to lipidated 
LC3B in SDS-PAGE. PLoS One, 8(9), e74222. 
doi:10.1371/journal.pone.0074222 
Wang, Y., & Pessin, J. E. (2013). Mechanisms for fiber-type specificity of skeletal 
muscle atrophy. Curr Opin Clin Nutr Metab Care, 16(3), 243-250. 
doi:10.1097/MCO.0b013e328360272d 
Yamada, E., Bastie, C. C., Koga, H., Wang, Y., Cuervo, A. M., & Pessin, J. E. (2012). 
Mouse skeletal muscle fiber-type-specific macroautophagy and muscle wasting 
61 
 
are regulated by a Fyn/STAT3/Vps34 signaling pathway. Cell Rep, 1(5), 557-569. 
doi:10.1016/j.celrep.2012.03.014 
Yoon, Y. H., Cho, K. S., Hwang, J. J., Lee, S. J., Choi, J. A., & Koh, J. Y. (2010). 
Induction of lysosomal dilatation, arrested autophagy, and cell death by 
chloroquine in cultured ARPE-19 cells. Invest Ophthalmol Vis Sci, 51(11), 6030-
6037. doi:10.1167/iovs.10-5278 
Yoshii, S. R., & Mizushima, N. (2015). Autophagy machinery in the context of 
mammalian mitophagy. Biochim Biophys Acta, 1853(10 Pt B), 2797-2801. 
doi:10.1016/j.bbamcr.2015.01.013 
Yoshii, S. R., & Mizushima, N. (2017). Monitoring and Measuring Autophagy. Int J Mol 
Sci, 18(9). doi:10.3390/ijms18091865 
Zeharia, A., Shaag, A., Houtkooper, R. H., Hindi, T., de Lonlay, P., Erez, G., . . . Elpeleg, 
O. (2008). Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. 
Am J Hum Genet, 83(4), 489-494. doi:10.1016/j.ajhg.2008.09.002 
Zutt, R., van der Kooi, A. J., Linthorst, G. E., Wanders, R. J., & de Visser, M. (2014). 
Rhabdomyolysis: review of the literature. Neuromuscul Disord, 24(8), 651-659. 
doi:10.1016/j.nmd.2014.05.005 
  
 
